A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 112
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : QFT-G
Long Form : QuantiFERON-TB Gold
No. Year Title Co-occurring Abbreviation
2020 Prevalence of Positive QuantiFERON-TB Gold In-Tube Test in Uveitis and its Clinical Implications in a Country Nonendemic for Tuberculosis. TB
2019 Risk factors for active tuberculosis in 938 QuantiFERON-positive schoolchildren in Mongolia: a community-based cross-sectional study. aRR, BCG, TB
2019 The Risk of Latent Tuberculosis Infection in Respiratory Therapists in a Country with Intermediate Incidence. HCWs, RTs, TB
2018 Looking for Ocular Tuberculosis: Prevalence and Clinical Manifestations of Patients with Uveitis and Positive QuantiFERON-TB Gold Test. TST
2018 Screening for latent tuberculosis infection among patients with rheumatoid arthritis in the era of biologics and targeted synthetic disease-modifying anti-rheumatic drugs in India, a high-burden TB country: The importance of Mantoux and Quantiferon-TB Gold tests. a-TST, LTBI, RA, TU
2017 Indeterminate QuantiFERON-TB Gold Increases Likelihood of Inflammatory Bowel Disease Treatment Delay and Hospitalization. anti-TNF, IBD, IPTW, LTBI
2017 Latent tuberculosis infection screening prior to biological treatment in Tunisian patients. CID, LTBI, TST
2017 Serial QuantiFERON-TB Gold testing in patients with psoriasis treated with ustekinumab. LTBI
2016 A prospective cohort study of latent tuberculosis in adult close contacts of active pulmonary tuberculosis patients in Korea. 4RIF, 9INH, LTBI, TB, TST
10  2016 Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation. ICER, IGRAs, LTBI, Mtb, NICE, QALY, QFT-GIT, TB, TSTs
11  2016 Concordance between the tuberculin skin test and interferon gamma release assay (IGRA) for diagnosing latent tuberculosis infection in patients with systemic lupus erythematosus and patient characteristics associated with an indeterminate IGRA. BCG, IGRA, LTBI, RA, SLE, SLEDAI, TST
12  2016 Elevated Neopterin Levels Are Associated with Increased Tuberculosis Risk in Rheumatoid Arthritis Patients with QuantiFERON Conversion during Biologic Therapy. non-RA TB, RA, RA-TB, TB
13  2016 Impact of socioeconomic status and living condition on latent tuberculosis diagnosis among the tribal population of Melghat: A cohort study. AOR, CI, LC, LTBI, SES, TST
14  2016 Interferon-gamma release assays in patients with Mycobacterium kansasii pulmonary infection: A retrospective survey. IGRAs, M. kansasii, QFT-GIT
15  2016 Predictive value of the tuberculin skin test and QuantiFERON-tuberculosis Gold In-Tube test for development of active tuberculosis in hemodialysis patients. HD, LTBI, QFG-IT, TB, TST
16  2016 Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country. AOR, BCG, HIV, IDUs, IGRAs, LTBI, QFT-GIT, TB, TST
17  2016 Review of Results of QuantiFERON TB Gold Test in Presumed Ocular Tuberculosis in a South Indian Patient Population. ATT
18  2016 Screening of latent tuberculosis infection by interferon-gamma release assays in rheumatic patients: a systemic review and meta-analysis. CI, DMARDs, IGRAs, LTBI, OR, QFT-GIT, TB, TST
19  2015 Diagnostic Utility of QuantiFERON-TB Gold (QFT-G) in Active Pulmonary Tuberculosis. KAMC-R, TB
20  2015 Enhanced Tuberculosis Infection Treatment Outcomes after Implementation of QuantiFERON-Gold Testing. BCG, LTBI, TST
21  2015 Prevalence of latent tuberculosis infection in BCG-vaccinated healthcare workers by using an interferon-gamma release assay and the tuberculin skin test in an intermediate tuberculosis burden country. BCG, HCWs, LTBI, TB, TST
22  2015 Quantiferon TB-Gold conversion can predict active tuberculosis development in elderly nursing home residents. TB, TST
23  2015 The diagnostic accuracy of tests for latent tuberculosis infection in hemodialysis patients: a systematic review and meta-analysis. TST
24  2015 Tuberculous meningitis with dementia as the presenting symptom after intramedullary spinal cord tumor resection. CSF, TB
25  2014 Cost-effectiveness of using Quantiferon Gold (QFT-G) versus tuberculin skin test (TST) among U.S. and foreign born populations at a public health department clinic with a low prevalence of tuberculosis. TST
26  2014 Detection of IFN-gamma for latent tuberculosis diagnosis using an anodized aluminum oxide-based capacitive sensor. AAO, IFN-gamma, LTBI
27  2014 Latent TB infection diagnosis in population exposed to TB subjects in close and poor ventilated high TB endemic zone in India. BMI, LTBI, TST
28  2014 Latent Tuberculosis screening using interferon-gamma release assays in an Australian HIV-infected cohort: is routine testing worthwhile? CI, LTBI
29  2014 Performance of QuantiFERON TB Gold test in detecting latent tuberculosis infection in brain-dead organ donors in Iran: a brief report. CFP-10, ELISA, ESAT-6, NRITLD
30  2014 Risk factors for latent tuberculosis infection in close contacts of active tuberculosis patients in South Korea: a prospective cohort study. BCG, LTBI, TST
31  2014 Usefulness of QuantiFERON-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers. LTBI, TNF
32  2013 Comparison of Quantiferon-TB Gold versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease patients. BCG, IBD, IST, LTB, TST
33  2013 Cost-effectiveness of QuantiFERON testing before initiation of biological therapy in inflammatory bowel disease. IBD, TB, TST
34  2012 A Case of Peritoneal Tuberculosis Developed after Infliximab Therapy for Refractory RA. LTBI, TB, TST
35  2012 Biphasic emergence of active tuberculosis in rheumatoid arthritis patients receiving TNFalpha inhibitors: the utility of IFNgamma assay. IFN-gamma, RA, TNF-alpha, TST
36  2012 Comparison of QuantiFERON-TB Gold test and tuberculin skin test for the identification of latent Mycobacterium tuberculosis infection in lupus patients. BCG, HCs, LTBI, SLE, TB, TST
37  2012 Cost-effectiveness of different screening strategies (single or dual) for the diagnosis of tuberculosis infection in healthcare workers. BCG, HCWs, LTBI, TST
38  2012 Interferon-gamma release assays for the diagnosis of Mycobacterium tuberculosis infection in children: a literature review. IGRAs, QFT-GIT, TST
39  2012 Rapid diagnosis of Mycobacterium tuberculosis infection in children using interferon-gamma release assays (IGRAs). BCG, IGRAs, LTBI, TB, TST
40  2012 The diagnostic efficiency of QuantiFERONTB-Gold test in the diagnosis of tuberculous pleurisy. ADA, IGRAs
41  2012 Use of adenosine deaminase measurements and QuantiFERON in the rapid diagnosis of tuberculous peritonitis. ADA, NPV, PPV, TB
42  2012 Utility of interferon-gamma release assay results to monitor anti-tubercular treatment in adults and children. IGRAs, QTF-G-IT
43  2012 Utility of QuantiFERON-TB Gold test in diagnosis and management of suspected tubercular uveitis in India. TB
44  2012 [Can an individual with a positive baseline QuantiFERON test result develop active tuberculosis?]. TB
45  2012 [Reproducibility of the QFT-G-IT assay in the contact examination in which a high positive rate was shown independent of contact time]. IFN, QFT-GIT, TB
46  2011 Acceptance of interferon-gamma release assay by a high-risk urban cohort. LTBI, TST
47  2011 Analysis of an interferon-gamma release assay for monitoring the efficacy of anti-tuberculosis chemotherapy. IFN-gamma
48  2011 Clinical experience of QuantiFERON() -TB Gold testing in patients with psoriasis treated with tumour necrosis factor blockers in Taiwan. LTBI, TNF
49  2011 Distinguishing tuberculosis from Mycobacterium avium complex disease using an interferon-gamma release assay. IGRAs, MAC, QFT, TB, TST
50  2011 Indeterminate QuantiFERON-TB Gold results in a public health clinic setting. ---
51  2011 Influence of previous tuberculin skin test on serial IFN-gamma release assays. IGRAs, QFT-GIT, TST
52  2011 Interferon-inducible protein-10 as a marker to detect latent and active tuberculosis in rheumatoid arthritis. CFP-10, ESAT-6, IFN-gamma, IP-10, LTBI, RA, TB, TNF-alpha, TST
53  2011 No influence of haemodialysis on interferon production in the QuantiFERON-TB Gold-In-Tube test. ESRD, HD, LTBI, TB
54  2011 Performance of a Whole-Blood Interferon-Gamma Release Assay with Mycobacterium RD1-Specific Antigens among HIV-Infected Persons. TB
55  2011 Programmatic impact of using QuantiFERON-TB Gold in routine contact investigation activities. LTBI, TST
56  2011 QuantiFERON-TB Gold test for screening latent tuberculosis infection in hemodialysis patients. LTBI, TST
57  2011 Reversion rates of QuantiFERON-TB Gold are related to pre-treatment IFN-gamma levels. IFN
58  2011 The sensitivity of interferon-gamma release assays is not compromised in tuberculosis patients with diabetes. IGRAs, TB
59  2011 Tuberculosis screening programme using the QuantiFERON-TB Gold test and chest computed tomography for healthcare workers accidentally exposed to patients with tuberculosis. CT, HCWs, TB
60  2010 Comparison of the QuantiFERON-TB Gold assay and tuberculin skin test to detect latent tuberculosis infection among target groups in Trinidad & Tobago. LTBI, TST
61  2010 Costs of QuantiFERON-TB Gold versus tuberculin skin test in Spanish healthcare workers. TST
62  2010 HRCT and whole-blood interferon-gamma assay for the rapid diagnosis of smear-negative pulmonary tuberculosis. HRCT, IGRA, PCR, PTB
63  2010 Impact of peripheral lymphocyte count on the sensitivity of 2 IFN-gamma release assays, QFT-G and ELISPOT, in patients with pulmonary tuberculosis. ELISPOT
64  2010 Performance of QuantiFERON-TB Gold test compared to tuberculin skin test in detecting latent tuberculosis infection in HIV- positive individuals in Iran. BCG, ELISA, HAART, IGRA, LTBI, PPD, TB, TST
65  2010 Systematic review of interferon-gamma release assays in tuberculosis: focus on likelihood ratios. LR, LTBI, NLR, PLR
66  2010 Use of the QuantiFERON-TB Gold test for screening tuberculosis contacts and predicting active disease. TB
67  2010 Usefulness and limitations of QuantiFERON-TB Gold in Japanese rheumatoid arthritis patients: proposal to decrease the lower cutoff level for assessing latent tuberculosis infection. anti-TB, AUC, CT, IFN-gamma, RA, ROC, TB, TNF
68  2009 Annual incidence of latent tuberculosis infection among newly employed nurses at a tertiary care university hospital. TB, TST
69  2009 Combined use of QuantiFERON-TB Gold assay and chest computed tomography in a tuberculosis outbreak. CT, TB, TST
70  2009 Comparison of 2 interferon-gamma assays and Roche Cobas Amplicor Mycobacterium tuberculosis assay for rapid diagnosis of tuberculosis among patients with suspected tuberculosis in Taiwan. IFN-gamma, PCR, RCA-TB, TB
71  2009 Comparison of intracellular cytokine flow cytometry and an enzyme immunoassay for evaluation of cellular immune response to active tuberculosis. ELISA, ICC, IL-4, TB
72  2009 Comparison of performance in two diagnostic methods for tuberculosis infection. ---
73  2009 Comparison of tuberculin skin test with a whole-blood interferon gamma assay and ELISA, in HIV positive children and adolescents with TB. ELISA, HIV, IGRA, TB, TST
74  2009 Contact investigation in a primary school using a whole blood interferon-gamma assay. TST
75  2009 Differences in tuberculin reactivity as determined in a veterans administration employee health screening program. ---
76  2009 Discordant tuberculin skin and interferon-gamma tests during contact investigations: a dilemma for tuberculosis controllers. TB, TST
77  2009 Estimation of incidence of tuberculosis infection in health-care workers using repeated interferon-gamma assays. HCWs, Mtb, TB
78  2009 Evaluation of whole blood IFNgamma test using PPD and recombinant antigen challenge for diagnosis of pulmonary and extra-pulmonary tuberculosis. AFB, EPTB, NTM, PTB
79  2009 High prevalence of latent tuberculosis infection in patients in end-stage renal disease on hemodialysis: Comparison of QuantiFERON-TB GOLD, ELISPOT, and tuberculin skin test. BCG, CI, ESRD, LTBI, PYs, TB, TST
80  2009 In vivo and in vitro effects of antituberculosis treatment on mycobacterial interferon-gamma T cell response. IFN
81  2009 Initial results of QuantiFERON-TB Gold testing in patients with uveitis. TB
82  2009 Interferon-gamma-release assays detect recent tuberculosis re-infection in elderly contacts. LTBI, TS.TB, TST
83  2009 QuantiFERON-TB Gold in the identification of latent tuberculosis infection in rheumatoid arthritis: a pilot study. IFN-gamma, LTBI, RA, TST
84  2009 Reducing the rates of indeterminate results of the QuantiFERON-TB Gold In-Tube test during routine preemployment screening for latent tuberculosis infection among healthcare personnel. ---
85  2009 Screening for tuberculosis infection in spanish healthcare workers: Comparison of the QuantiFERON-TB gold in-tube test with the tuberculin skin test. HCWs, LTBI, TST
86  2009 The evaluation of the Quantiferon-TB Gold test in pulmonary and extrapulmonary tuberculosis. TST
87  2009 Use of a T cell interferon gamma release assay in the investigation for suspected active tuberculosis in a low prevalence area. IGRA, TB
88  2009 Usefulness of the whole-blood interferon-gamma release assay for diagnosis of extrapulmonary tuberculosis. EPTB, TB
89  2008 Assessment of nosocomial transmission of tuberculosis in a psychiatric hospital using a whole blood interferon-gamma assay. HCWs, TB, TST
90  2008 Comparison of the interferon- gamma release assay and the tuberculin skin test for contact investigation of tuberculosis in BCG-vaccinated health care workers. TST
91  2008 Comparison of the sensitivity and specificity of two whole blood interferon-gamma assays for M. tuberculosis infection. QFT-GIT, TB
92  2008 Cost-effectiveness of a new interferon-based blood assay, QuantiFERON-TB Gold, in screening tuberculosis contacts. BCG, INMB, LTBI, TST
93  2008 Discordant QuantiFERON-TB Gold test results among US healthcare workers with increased risk of latent tuberculosis infection: a problem or solution? HCWs, IR, LTBI, TST
94  2008 Interferon-gamma release assays for diagnosing mycobacterium tuberculosis infection in renal dialysis patients. ESRD, TB, TST
95  2008 Interferon-gamma responses after isoniazid chemotherapy for latent tuberculosis. CFP, IFN
96  2008 Low sensitivity of T-cell based detection of tuberculosis among HIV co-infected Tanzanian in-patients. TST
97  2008 QuantiFERON-TB Gold assay for the diagnosis of latent tuberculosis infection. TB, TST
98  2008 Relationship between whole-blood interferon-gamma responses and the risk of active tuberculosis. IFN-gamma, Mtb, TB
99  2008 Reproducibility of QuantiFERON-TB gold in-tube assay. QFT-G-IT, TST
100  2008 Whole-blood interferon-gamma assay for the diagnosis of tuberculosis infection in an unselected Greek population. LTBI, TST